Consistent with previous report, we found that METTL14 was upregulated in patients with AML and overexpressed METTL14 could promote HL-60 cell proliferation, invasion and migration and inhibit the apoptosis in vitro. Here, METTL14 is linked to acute myeloid leukemia.